» Articles » PMID: 16631596

The Orphan Nuclear Receptor GCNF Recruits DNA Methyltransferase for Oct-3/4 Silencing

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2006 Apr 25
PMID 16631596
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Somatic DNA methylation patterns are determined in part by the de novo methylation that occurs after early embryonic demethylation. Oct-3/4, a pluripotency gene, is unmethylated in the blastocyst, but undergoes de novo methylation and silencing during gastrulation. Here we show that the transcriptional repressor GCNF recruits DNA methyltransferase to the Oct-3/4 promoter and facilitates its methylation. Although acetylation of histone H3 at lysine 9 (K9) and/or 14 (K14) and methylation of H3 at lysine 4 (K4) decrease during this period, as do Oct-3/4 transcript levels, H3K9 and H3K27 methylation levels remain constant, indicating that DNA methylation does not require repressive histone modifications. We found that GCNF interacts directly with Dnmt3 molecule(s) and verified that this interaction induces the methylation of the Oct-3/4 promoter. Our finding suggests a model in which differentiation-induced GCNF recruits de novo DNA methyltransferase and facilitates the silencing of a pluripotency gene.

Citing Articles

Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis.

Andreeva O, Sorokin D, Vinokurova S, Kopnin P, Elkina N, Katargin A Cancer Drug Resist. 2024; 7:48.

PMID: 39624078 PMC: 11609143. DOI: 10.20517/cdr.2024.69.


The expanding roles of Nr6a1 in development and evolution.

Li J, Mascarinas P, McGlinn E Front Cell Dev Biol. 2024; 12:1357968.

PMID: 38440075 PMC: 10909835. DOI: 10.3389/fcell.2024.1357968.


Thyroid hormone links environmental signals to DNA methylation.

Seebacher F, Little A Philos Trans R Soc Lond B Biol Sci. 2024; 379(1898):20220506.

PMID: 38310936 PMC: 10838643. DOI: 10.1098/rstb.2022.0506.


International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.

Burris T, de Vera I, Cote I, Flaveny C, Wanninayake U, Chatterjee A Pharmacol Rev. 2023; 75(6):1233-1318.

PMID: 37586884 PMC: 10595025. DOI: 10.1124/pharmrev.121.000436.


PHF14 enhances DNA methylation of SMAD7 gene to promote TGF-β-driven lung adenocarcinoma metastasis.

Tian H, Liu C, Yu J, Han J, Du J, Liang S Cell Discov. 2023; 9(1):41.

PMID: 37072414 PMC: 10113255. DOI: 10.1038/s41421-023-00528-0.